Where does University of Strathclyde rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), University of Strathclyde ranks #7,792 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does University of Strathclyde hold?

University of Strathclyde holds 42 US utility patents granted between 2015 and 2025, spanning 49 technology areas.

What is University of Strathclyde's Innovation Score?

University of Strathclyde has an Innovation Score of 55.5 out of 100 (top 7% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does University of Strathclyde focus on?

University of Strathclyde's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 7 patents, ranking #515 of 1,943 assignees active in that subclass. Grants appear in 49 CPC subclasses total.

Is University of Strathclyde's patent grant rate increasing or decreasing?

University of Strathclyde's recent grant velocity is +5% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for University of Strathclyde's patents?

University of Strathclyde's patents average 18.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the University of Strathclyde patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

University of Strathclyde

USPTO PatentsView assignee record - 42 granted patents across 49 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, University ranks #7,792 of 49,997 tracked US assignees by granted-patent volume, with 42 patents across 49 technology areas.

#7,792
of 49,997 US assignees by volume: Top 7%
by Innovation Score (55.5/100): 18.5
avg claims per patent: +5%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7792 · Foreign Corporation #7,792 · 42 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 42 grants
UPPER-Q #7,792/49,997
PHOTO-FINISH Thin Film ASA
CPC-WIDE A61N · 49 areas
INNOV-PAR 55.5/100
CLAIMS-RICH 18.5 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT +5% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Thin Film Electronics ASA (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How University’s 55.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.0 pts (23%) Velocity 6.7 pts (12%) Breadth 24.7 pts (45%) Claim depth 11.1 pts (20%)

Qualcomm Incorporated · highest

85
Nippon Shokubai · near

56
University of… · this assignee

56
Joulwatt Technology · near

56
Recursion Pharmaceut… · near

56
SK microworks · near

56
3D Lighting… · lowest

7

What this shows University's Innovation Score is 55.5/100 (top 7% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for University?

Each dot is one of University’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). University’s own 18.5 claims/patent is ABOVE the 17.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

University vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where University's grants concentrate

University of Strathclyde is a focused PatentsView assignee: 49 CPC subclasses with 16.7% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2016 (8 grants) versus a trough of 2 in 2018. By volume, University sits between Thin Film Electronics ASA and Vision RT Limited.

University's three-year grant acceleration

University of Strathclyde shows 12 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Thin Film ASA

42
Throughputer

42
Universitat DE Ba…

42
USAI

42
University of Sur…

42
Viavi Solutions UK

42
Visa Europe

42
Vision RT

42
University of Str… ◀

42

What this shows University holds 42 patents at rank #7,792, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near University

By rank, the assignees closest to #7,792 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in University's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for University, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), University ranks #515 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (56 here).

Nippon Shokubai Co., Ltd. 56 Joulwatt Technology Co., Ltd. 56 Recursion Pharmaceuticals, Inc. 56 SK microworks Co., Ltd. 56

University's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

56 Top 7% higher than 93% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

University of Strathclyde patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	9.5%
2016	8	19.0%
2017	3	7.1%
2018	2	4.8%
2019	3	7.1%
2020	4	9.5%
2021	5	11.9%
2022	2	4.8%
2023	4	9.5%
2024	6	14.3%
2025partial year	1	2.4%

Which technologies does University of Strathclyde patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 7

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 7

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 7

A61B - DIAGNOSIS; SURGERY; Identification 6

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 6

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 6

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 5

Y02A - Technologies FOR Adaptation TO Climate Change 4

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 4

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 3

C07K - Peptides 3

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 3

Y10T - Technical Subjects Covered BY Former US Classification 3

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

H05H - Plasma Technique ; Production OF Accelerated Electrically-charged Particles OR OF NEUTRONS; Production OR Acceleration OF Neutral Molecular OR Atomic Beams 2

Top 15 of 49 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

University of Strathclyde's patent record in context - here's where to go next.

University of Strathclyde's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 16.7% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #7,792 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare University of Strathclyde against Thin Film Electronics ASA, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 55.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.